Related Experiment Video
Updated: Jul 3, 2026

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
Lack of expression of podoplanin by microvenular hemangioma
1Service of Anatomic Pathology, Hospital El Bierzo, Ponferrada, Spain. gpyauflowerlion@terra.es
Abstract:
Microvenular hemangioma (MH) is not a very common type of hemangioma, and it can occasionally be difficult to distinguish it from other benign vascular tumors and malignant tumors such as Kaposi's sarcoma. The latter has been shown to be negative for the marker D2-40. Nevertheless, the status of MH for D2-40 has not been established yet. We therefore studied the expression of podoplanin in three cases of MH using D2-40 antibody. No expression was seen, while the dermal lymphatics were clearly immunostained. Nevertheless, the vessels of the MHs were positive for CD34, CD31, and von Willebrand Factor. This study adds MH to the list of vascular lesions that fail to express the allegedly lymphatic marker podoplanin.
More Related Videos
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
08:26A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
Published on: April 12, 2018
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis